key: cord-0713282-hocng7a8
authors: Bailly, Laurent; Fabre, Roxane; Courjon, Johan; Carles, Michel; Dellamonica, Jean; Pradier, Christian
title: Obesity, diabetes, hypertension and severe outcomes among inpatients with COVID-19: a nationwide study
date: 2021-09-16
journal: Clin Microbiol Infect
DOI: 10.1016/j.cmi.2021.09.010
sha: 5e5f73164a2c034f094433e47a1978bae6153a0e
doc_id: 713282
cord_uid: hocng7a8

OBJECTIVES: Initial studies of COVID-19 patients revealed that obesity, diabetes and hypertension were associated with severe outcomes. Subsequently, some authors showed that the risk could vary according to age, gender, comorbidities and medical history. In a nationwide retrospective cohort, we studied the association between these comorbidities and patients’ requirement for invasive mechanical ventilation (IMV) or their death. METHODS: All French COVID-19 adult inpatients admitted during the first epidemic wave (February to September 2020) were included. When patients were diagnosed with obesity, diabetes or hypertension for the first time in 2020, these conditions were considered as incident comorbidities, otherwise as prevalent. We compared outcomes of IMV and in-hospital death according to obesity, diabetes, and hypertension, taking age, gender and Charlson’s comorbidity index score (CCIS) into account. RESULTS: 134,209 adult inpatients with COVID-19 were included, half of them had hypertension (N=66,613, 49.6%) and one in four were diabetic (N=32,209, 24.0%) or with obesity (N=32,070, 23.9%). Among this cohort, IMV was required for 13,596 inpatients, and 19,969 patients died. IMV and death were more frequent in male patients (Adj.OR=2.0 [95%CI:1.9-2.1] and Adj.OR=1.5 [95%CI:1.4-1.5], respectively), IMV in patients with comorbidities (Adj.OR=2.1 [95%CI:2.0-2.2] for CCIS=2 and Adj.OR=3.0 [95%CI:2.8-3.1] for CCIS≥5), and death in patients aged 80 or above (Adj.OR=17.0 [95%CI:15.5-18.6]). Adjusted on age, gender and CCIS, death was more frequent among inpatients with obesity (Adj.OR=1.2 [95%CI:1.1-1.2]) and diabetes (Adj.OR=1.2 [95%CI:1.1-1.2]). IMV was more frequently necessary for inpatients with obesity (Adj.OR=1.9 [95%CI:1.8-2.0]), diabetes (Adj.OR=1.4 [95%CI:1.3-1.4]) and hypertension (Adj.OR=1.7 [95%CI:1.6-1.8]). Comparatively, IMV was more often required for patients with the following incident comorbidities: obesity (Adj.OR=3.5 [95%CI:3.3-3.7]), diabetes (Adj.OR=2.0 [95%CI:1.8-2.1]) and hypertension (Adj.OR=2.5 [95%CI:2.4-2.6]). CONCLUSIONS: Among 134,209 inpatients with COVID-19, mortality was more frequent among patients with obesity and diabetes. IMV was more frequently necessary for inpatients with obesity, diabetes and hypertension. Patients for whom these were incident comorbidities were particularly at risk. Specific medical monitoring and vaccination should be priorities for patients with these comorbidities.

Obesity diabetes hypertension and severe outcomes among inpatients with COVID-19: a nationwide study Bailly Initial studies of COVID-19 patients revealed that obesity, diabetes and hypertension were 22 associated with severe outcomes. Subsequently, some authors showed that the risk could vary 23 according to age, gender, comorbidities and medical history. In a nationwide retrospective 24 cohort, we studied the association between these comorbidities and patients' requirement for 25 invasive mechanical ventilation (IMV) or their death. 26 

All French COVID-19 adult inpatients admitted during the first epidemic wave (February to 28 September 2020) were included. When patients were diagnosed with obesity, diabetes or 29 hypertension for the first time in 2020, these conditions were considered as incident 30 comorbidities, otherwise as prevalent. We compared outcomes of IMV and in-hospital death 31 according to obesity, diabetes, and hypertension, taking age, gender and Charlson's 32 comorbidity index score (CCIS) into account. 33 death, were more often those with diabetes or hypertension, and a meta-analysis confirmed 70 these findings (5). Identifying individuals most at risk is of paramount importance to 71 adequately target the currently available anti-COVID-19 vaccines. 72 In the Western world, studies of comorbidities associated with an unfavourable outcome 73 pointed to obesity (6) and diabetes (7) as the main risk factors (8, 9). Concomitantly, a 74 nationwide study conducted on 87,000 American army veterans who had been screened for 75 SARS-Cov-2 failed to demonstrate a correlation between obesity and the occurrence of severe 76 disease, mechanical ventilation or death, after adjusting for comorbidities (10). Table 3 . Overall, after adjusting for age, gender and CCIS, in-hospital mortality 181 after IMV was significantly higher among patients with a prevalent comorbidity: obesity, 182 diabetes or hypertension. 183 Figure 1 shows total in-hospital mortality, use of IMV and mortality following IMV, as well 184 as mean CCIS among non-obese patients, those with incident or with prevalent obesity, by 185 age group. Total in-hospital mortality was higher among patients with prevalent obesity than 186 among those with incident obesity or non-obese patients. In contrast, among patients with 187 incident obesity, requirement for IMV was threefold that of non-obese patients, and twice that Moreover, the fact that, during the first epidemic wave, there was no established strategy to comorbidities were twice as likely to need IMV compared to patients with pre-existing 227 conditions and three times more compared to patients with none of these comorbidities. 228 Mortality following IMV was not higher among patients with incident obesity and diabetes or 229 hypertension than among patients free of these conditions, as opposed to patients in whom 230 they were prevalent. A lack of association between obesity and in-hospital mortality has 231 already been reported among patients with class I and II obesity by the American Heart 232 Association COVID-19 Cardiovascular Disease Registry (30), while, according to that study, 233 patients with obesity required IMV more frequently, regardless of the class. 234 Our study presents some limits, firstly COVID-19 patient identification relies on ICD-10 235 coding for this condition, and not directly from laboratory test results, but this disease 236 identification method based on ICD-10 codes has already been used in France for obesity 237 (16), namely for patients with COVID-19 (14). Our hospital-based cohort only includes 238 COVID-19 patient deaths that occurred in hospital, so that any death following discharge, e.g. 

WHO Director-General's opening remarks at the media briefing on

general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-273 on-covid

COVID-19 pandemic

European Centre for Disease Prevention and Control

Coronavirus Disease 2019 in China

Comorbidity and its 279 impact on 1590 patients with COVID-19 in China: a nationwide analysis

Prevalence and severity of corona 282 virus disease 2019 (COVID-19): A systematic review and meta-analysis

High 285 prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) 286

requiring invasive mechanical ventilation

Diabetes as a risk factor for greater 288

COVID-19 severity and in-hospital death: A meta-analysis of observational studies. Nutr 289 positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort

Proportion of newly diagnosed diabetes 307 in COVID-19 patients: A systematic review and meta-analysis

Comparison 310 of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a 311 nationwide, population-based retrospective cohort study

Successful linkage of French large-scale national registry populations to national 315 reimbursement data: Improved data completeness and minimized loss to follow-up

Colorectal Cancer Risk Following Bariatric 318

Surgery in a Nationwide Study of French Individuals With Obesity

Mise à jour des consignes de codage des séjours COVID-19 | Publication ATIH

Disponible sur

A new method of classifying 324 prognostic comorbidity in longitudinal studies: development and validation

Coding 327 algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med 328 Care

Guidance 330 on reporting multivariable regression models in CMI

Death after invasive mechanical ventilation % (N)